(Q53343354)

13 May 2018

title

Prevalence of dysthymic disorder in primary care. (English)

1 reference

13 May 2018

0 references

Steiner M

1

1 reference

13 May 2018

Bell B

2

1 reference

13 May 2018

Browne G

3

1 reference

13 May 2018

Roberts J

4

1 reference

13 May 2018

Gafni A

5

1 reference

13 May 2018

Byrne C

6

1 reference

13 May 2018

Dunn E

7

1 reference

13 May 2018

Chalkin L

8

1 reference

13 May 2018

Kraemer J

9

1 reference

13 May 2018

Mills M

10

1 reference

13 May 2018

Wallik D

11

1 reference

13 May 2018

publication date

1 August 1999

1 reference

13 May 2018

Journal of Affective Disorders

published in

1 reference

13 May 2018

volume

54

1 reference

13 May 2018

issue

3

1 reference

13 May 2018

page(s)

303-308

1 reference

13 May 2018

Dysthymic disorder: psychopathology of proposed chronic depressive subtypes

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

Dysthymia and cyclothymia: historical origins and contemporary development

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

Depression, disability days, and days lost from work in a prospective epidemiologic survey

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

Development of a brief screening instrument for detecting depressive disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

Comorbidity between dysthymic and major depressive disorders: A family study analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

Major depressive disorder and dysthymia in young adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

General health, health care utilization, and medical comorbidity in dysthymia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

Dysthymia in clinical practice:course, outcome and impact on the community.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

"Double depression": superimposition of acute depressive episodes on chronic depressive disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

Family study of early-onset dysthymia. Mood and personality disorders in relatives of outpatients with dysthymia and episodic major depression and normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

Imipramine treatment for chronic depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

Social adjustment in dysthymia, double depression and episodic major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

Amisulpride versus imipramine and placebo in dysthymia and major depression. Amisulpride Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

One-year prevalence of psychiatric disorder in Ontarians 15 to 64 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

Controlled efficacy study of fluoxetine in dysthymia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

Anxiety and depression in a primary care clinic. Comparison of Diagnostic Interview Schedule, General Health Questionnaire, and practitioner assessments.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

The epidemiology of dysthymia in five communities: rates, risks, comorbidity, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2898%2900189-X

7 January 2021

10.1016/S0165-0327(98)00189-X

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018